[1]
|
ADA Statement (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care, 36, 67-74.
doi:10.2337/dc13-S067
|
[2]
|
Kahn, S.E. (2003) The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46, 193-194.
|
[3]
|
Steppel, J.H. and Horton, E.S. (2004) Beta-cell failure in the pathogenesis of type 2 diabetes mellitus. Current Diabetes Report, 4, 169-175.
doi:10.1007/s11892-004-0019-3
|
[4]
|
Fong, D.S., Aiello, L.P., Ferris, F.L., et al. (2004) Diabetic retinopathy. Diabetes Care, 27, 2540-2553.
doi:10.2337/diacare.27.10.2540
|
[5]
|
Gross, J.L., de Azevedo, M.J., Silveiro, S.P., et al. (2005) Diabetic nephropathy: Diagnosis, prevention and treatment. Diabetes Care, 28, 164-176.
doi:10.2337/diacare.28.1.164
|
[6]
|
Zachary, T. and Bloomgarden, M.D. (2004) Diabetes complications. Diabetes Care, 27, 1506-1514.
doi:10.2337/diacare.27.6.1506
|
[7]
|
Kim, V.N. and Nam, J.W. (2006) Genomics of microRNAs. Trends in Genetics, 22, 165-173.
doi:10.1016/j.tig.2006.01.003
|
[8]
|
Sebastiani, G., Vendrame, F. and Dotta, F. (2011) MicroRNAs as new tools for exploring type-1 Diabetes: Relevance for immunomodulation and transplantation therapy. Transplntation Proceedings, 43, 330-332.
doi:10.1016/j.transproceed.2010.09.104
|
[9]
|
Mitchell, P.S., Patrik, K.M., Kroh, E.M., et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings National Academy of Science of the United States of America, 105, 1051310518. doi:10.1073/pnas.0804549105
|
[10]
|
Adachi, T., Nakanishi, M., Otsuka, J., et al. (2010) Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clinical Chemistry, 56, 1733-1741.
doi:10.1373/clinchem.2010.144121
|
[11]
|
Wang, K., Zhang, S., Marzolf, B., et al. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proceedings National Academy of Science of the United States of America, 106, 4402-4407.
doi:10.1073/pnas.0813371106
|
[12]
|
Zampetaki, A., Kiechl, S., Drozdov, I., et al. (2012) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation Research, 107, 810-817.
doi:10.1161/CIRCRESAHA.110.226357
|
[13]
|
Kong, L., Zhu, J., Han, W., et al. (2011) Significance of serum microRNA in pre-diabetes and newly diagnosed type 2 diabetes: A clinical study. Acta Diabetologica, 48, 61-69. doi:10.1007/s00592-010-0226-0
|
[14]
|
Wang, K., Yuan, Y., Cho, J.H., et al. (2012) Com paring the microRNA spectrum between serum and plasma. PLoS ONE, 7, e14561.
|
[15]
|
Kovacs, B., Lumayag, S., Cowan, C., et al. (2011) MicroRNAs in early diabetic retinopathy in streptozotocininduced diabetic rats. Investigative Ophthalmology and Visual Science, 52, 4402-4409.
doi:10.1167/iovs.10-6879
|
[16]
|
Avogaro, A., Albiero, M., Menegazzo, L., et al. (2011) Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care, 34, 285-290.
doi:10.2337/dc11-s239
|
[17]
|
Egan, C.G., Lavery, R., Caporali, F., et al. (2008) Genera lised reduction of putative endothelial progenitors and CXCR4 positive peripheral blood cells in type 2 diabetes. Diabetologia, 51, 1296-1305.
doi:10.1007/s00125-008-0939-6
|
[18]
|
Hasegawa, G., Nakano, K., Sawada, M., et al. (1991) Possible role of tumor-necrosis-factor and interleukin-1 in the development of diabetic nephropathy. Kidney International, 40, 1007-1012. doi:10.1038/ki.1991.308
|
[19]
|
Satoh, J., Yagihashi, S. and Toyota, T., (2003) The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Experimental Diabesity Research, 4, 65-71.
doi:10.1155/EDR.2003.65
|
[20]
|
Suarez, Y., Fernandez-Hernando, C., Yu, J., et al. (2008) Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proceedings National Academy of Science of the United States of America, 105, 14082-14087. doi:10.1073/pnas.0804597105
|